Clinical Trial Update: Chronic Thromboembolic Disease Registry

View source ↗

Summary

A UC San Francisco-sponsored registry study on chronic thromboembolic disease and chronic thromboembolic pulmonary hypertension is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thromboembolic Disease
• Thromboembolic Pulmonary Hypertension

Snippet

Sponsor: University of California, San Francisco | Conditions: Chronic Thromboembolic Pulmonary Hypertension, Chronic Thromboembolic Disease | Status: RECRUITING